TP53 and EGFR Mutational Status in Thymoma: A Genetic Sequencing Study

BACKGROUND AND OBJECTIVE: Thymoma is a rare malignant tumor that usually with an indolent presentation, which was falsely assumed to be benign previously. The tumor suppressor P53 (TP53) and EGFR gene mutate most frequently in human cancers. We tried to investigate the presence of TP53 and EGFR muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Syahruddin, Elisna, Zaini, Jamal, Sembiring, Ruth, Baginta, Romy, Fadhillah, Muhamad Rizqy, Noor, Dimas Ramadhian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258671/
https://www.ncbi.nlm.nih.gov/pubmed/35092378
http://dx.doi.org/10.31557/APJCP.2022.23.1.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258671/
https://www.ncbi.nlm.nih.gov/pubmed/35092378
http://dx.doi.org/10.31557/APJCP.2022.23.1.109

Ejemplares similares